Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors.

Autor: You, Weir-Chiang1 (AUTHOR) bigjohnyou@vghtc.gov.tw, Lee, Hsu-Dung2 (AUTHOR), Pan, Hung-Chuan3 (AUTHOR), Chen, Hung-Chieh3 (AUTHOR)
Zdroj: Scientific Reports. 6/9/2023, Vol. 13 Issue 1, p1-9. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje